10-Minute Speech Practice That Doesn't Require Sitting Still

Last updated 2026-07-09

What is Lingraphica, and what do their AAC devices actually do?

Lingraphica is a New Jersey-based medical device company that has made speech-generating devices and communication apps since 1993. Their main products are purpose-built AAC devices that combine a touch screen, text-to-speech synthesis, and a symbol-based interface, so someone who can't produce clear spoken language can still communicate in real time.

The core idea is simple. A person taps a picture, a word, or a phrase on the screen, and the device speaks it aloud. Behind that simple interaction sits a lot of engineering: Lingraphica's devices use natural-sounding synthetic voices, allow pre-programmed personalized vocabulary, and offer several access methods including touch, switch access, and eye gaze on some models. ^[1]

Lingraphica's audience has always been adults, specifically people with aphasia after stroke or traumatic brain injury. That sets them apart from most other AAC manufacturers, who build devices for children with autism, cerebral palsy, or childhood apraxia of speech. If you're shopping for a child, Lingraphica probably isn't your first call, though their apps work across ages. ^[2]

The underlying AAC principles are the same no matter who uses the device. The American Speech-Language-Hearing Association defines AAC as "all of the ways we share our ideas and feelings without talking," and classifies speech-generating devices like Lingraphica's as aided high-tech AAC. ^[3]

What Lingraphica device models are available in 2026?

Lingraphica currently offers several product lines. Model names and features do change, so confirm current availability directly with Lingraphica or a certified AAC supplier. As of mid-2026, the main options include:

TalkPath Therapy and TalkPath Live: These are software apps, not dedicated hardware. TalkPath Therapy is a self-guided exercise platform for aphasia recovery. TalkPath Live connects users with speech-language pathologists over telehealth. Both run on iOS or Android.

The AllTalk device: This is Lingraphica's dedicated speech-generating device, a ruggedized tablet running proprietary software. It comes in different screen sizes (roughly 7-inch and 10-inch variants), and it's the product line that qualifies as a Medicare-covered SGD (speech-generating device) under HCPCS billing codes. ^[4]

The AllTalk includes Lingraphica's symbol library (over 10,000 picture icons), text-to-speech in multiple voices, and a core vocabulary layout alongside topic-specific pages. Users can record their own voice samples if they have any residual speech, or pick from pre-built synthetic voices.

If you're comparing Lingraphica against other dedicated SGD brands like Tobii Dynavox, PRC-Saltillo, or Liberator, the big difference is Lingraphica's heavy focus on aphasia-specific vocabulary and its in-house telehealth support. Other manufacturers serve a broader population including children, and often pack more into their access methods like eye gaze. ^[5]

How much does a Lingraphica AAC device cost?

A dedicated Lingraphica SGD retails between roughly $7,000 and $9,000 depending on model and configuration. ^[6] That number startles most families the first time they see it.

Here's the context that matters: most people who qualify never pay that full price out of pocket. Lingraphica has an in-house funding department that bills Medicare, Medicaid, and private insurers for the device. The company is a Medicare-enrolled supplier, which counts because Medicare Part B covers SGDs as Durable Medical Equipment (DME) when specific criteria are met. ^[4]

Under Medicare's SGD coverage rules, the beneficiary must have a severe expressive communication disorder, must have tried other AAC strategies, and must have documentation from a speech-language pathologist supporting medical necessity. Once approved, Medicare typically pays 80% of the allowed amount after the Part B deductible, and a Medigap or secondary plan often picks up the remaining 20%. ^[4]

Medicaid rules vary by state, but most state Medicaid programs cover SGDs for eligible adults and children. Private insurance is the wild card. Many plans cover SGDs as DME or under rehabilitation benefits, but you have to check yours.

Lingraphica also runs a free 30-day device trial, so the SLP and the user can test the device before committing to the funding process. That trial earns its keep. No amount of in-clinic demonstration tells you as much as living with a device for a month.

Does Medicare or Medicaid cover Lingraphica devices?

Yes, for people who qualify. Medicare Part B classifies dedicated speech-generating devices as Durable Medical Equipment under HCPCS codes E2500 through E2599. ^[4] Lingraphica bills directly as a Medicare supplier, so their funding team handles the prior authorization paperwork.

The Medicare LCD (Local Coverage Determination) for SGDs, maintained by Noridian Healthcare Solutions (the DME MAC for much of the country), says coverage requires documentation of a severe expressive communication disorder expected to be long-term, plus evidence that unaided communication (gestures, writing) and lower-tech options fall short. A licensed SLP must perform the evaluation and write the supporting documentation. ^[11]

Medicaid coverage runs state by state. All state Medicaid programs must address communication needs under federal law, but the prior auth process, documentation requirements, and approved vendors differ widely. ^[7] Lingraphica's funding specialists can check benefits for a specific state and plan.

For children, IDEA (Individuals with Disabilities Education Act) requires school districts to provide AT (assistive technology), including AAC devices, when an IEP team decides a child needs it for a free appropriate public education. That's a school-funded device, not a medical one, and it runs on a separate track from Medicare and Medicaid. ^[7] Lingraphica devices rarely turn up in pediatric IEP contexts given the company's adult focus, but the legal framework is the same regardless of manufacturer.

One thing to know: even with insurance approval, most SGD orders take 4 to 12 weeks from evaluation to delivery. Plan ahead.

Who should use a Lingraphica device vs. other AAC options?

Lingraphica devices are the clearest fit for adults who acquired aphasia from stroke or brain injury and who still have meaningful cognition but severe expressive language impairment. The vocabulary, therapy integration, and support model are all built around that population. ^[1]

If the person communicating is a child, especially one with autism, childhood apraxia of speech, or another developmental communication difference, Lingraphica usually isn't the first thing SLPs recommend. Devices from PRC-Saltillo (like the Accent series) or Tobii Dynavox (like the TD Snap system) have deeper feature sets for pediatric AAC, with more flexible vocabulary structures and access methods suited to kids. Device choice should always follow an in-person AAC evaluation by a certified SLP, not a brand preference. ^[3]

For adults with ALS or progressive neurological conditions, the math changes based on the rate of motor decline. Lingraphica offers some eye gaze capability, but companies like Tobii Dynavox have more mature eye gaze technology. Bring that up with the evaluating SLP.

For parents researching AAC for a child with a speech delay or autism, learn the broader AAC landscape first. Our article on AAC devices covers the full range from low-tech to high-tech, and our guide on autism spectrum speech therapy explains how AAC fits into a wider communication plan.

The right device is the one the person will actually use every day, in their real environment, with the vocabulary they need. Research on AAC consistently shows that access to a full vocabulary from the start produces better outcomes than starting with a small, limited system and expanding later. ^[8]

How does the Lingraphica AAC device evaluation and trial process work?

Getting a Lingraphica device starts with either contacting Lingraphica directly or having your SLP kick off the process. Lingraphica assigns a Regional Sales Manager who coordinates the trial.

The typical path looks like this:

1. The SLP (either your existing one or one Lingraphica connects you with) performs an AAC evaluation. This looks at the person's motor abilities, language comprehension, vision, cognition, and communication needs. 2. Lingraphica ships a trial device, usually the AllTalk model that seems like the best fit. 3. The 30-day trial period begins. The SLP, the user, and family members work with the device in real settings. 4. If the device fits, the SLP writes a letter of medical necessity (LMN) documenting the diagnosis, functional communication limitations, and why this specific device is needed. 5. Lingraphica's funding team submits to Medicare, Medicaid, or private insurance. 6. After approval, the device ships. If denied, Lingraphica typically helps with appeals.

The evaluation itself should be done by an SLP with AAC experience. ASHA's Special Interest Group 12 (Augmentative and Alternative Communication) points to resources for finding qualified evaluators. ^[3] Some states run AAC lending libraries through their AT Act programs, where you can trial multiple devices before committing to a brand.

If you don't have an SLP and you're exploring this for yourself or a family member, Lingraphica's TalkPath Live telehealth service can connect you with an SLP for an initial consultation, though a full in-person evaluation is usually required for the insurance documentation.

Does Lingraphica have apps, and are they different from the devices?

Yes, and the difference matters a lot for cost and coverage.

Lingraphica's TalkPath Therapy app is a standalone iOS and Android app for aphasia rehabilitation. It includes exercises for word finding, reading, writing, and speech. A basic version is free; a premium subscription costs around $24.99 per month (pricing subject to change). This is therapy practice software, not a speech-generating device, and insurance doesn't typically cover the subscription.

TalkPath Live is the telehealth piece, connecting users with SLPs for live sessions. Those sessions may bill through insurance as speech therapy visits, depending on the plan.

Neither app is the same as the AllTalk dedicated SGD. The dedicated device qualifies for Medicare DME coverage precisely because it's hardware, prescribed by a physician, and documented as medically necessary. An app running on a personal iPad does not qualify for SGD coverage under current Medicare rules, though policy discussions about this continue. ^[4]

Some families try a low-cost AAC app on a tablet instead of a dedicated device because the price gap is huge. That works for some users, but it has real downsides: tablets break and get repurposed for games, apps lack the durability and mounting options of dedicated devices, and the vocabulary systems in many consumer apps are thinner than dedicated SGD software. The SLP's evaluation should weigh that tradeoff honestly rather than defaulting to the cheapest option or the priciest one. ^[3]

For families of young children exploring lower-cost AAC app options alongside or before a formal device evaluation, tools like Little Words offer an AI-guided quiz to help you figure out where to start.

What does the research say about AAC devices and communication outcomes?

The evidence base for AAC is strong. A systematic review by Millar, Light, and Schlosser in the American Journal of Speech-Language Pathology found that "AAC interventions had a predominantly positive effect on the speech production of individuals who used AAC," which directly counters the persistent (and false) myth that using a device suppresses natural speech. ^[8]

For aphasia specifically, the research on SGDs as communication supports (distinct from therapy tools) is thinner than the research on behavioral therapy approaches like CILT or script training. Still, clinical consensus supports SGDs for people with severe chronic aphasia who haven't regained functional speech. ASHA's evidence maps for aphasia treatment document this. ^[3]

Lingraphica's own published research includes a 2019 study in Aphasiology showing TalkPath Therapy users improved significantly on standardized aphasia measures compared to a waitlist control group. That's a real study in a real peer-reviewed journal. Lingraphica funded it, which is standard in the medical device world but useful to keep in mind when you read the effect sizes. ^[9]

For children with developmental communication differences, the research on early AAC introduction is especially strong. A 2021 review in the Journal of Autism and Developmental Disorders found that children who got AAC support earlier showed better communication outcomes, and that there's no evidence AAC hinders speech development. ^[10] Lingraphica's devices aren't typically used in pediatric populations, but this research context matters for any family weighing AAC in general.

The bottom line from the literature: AAC works. Device choice matters less than implementation quality, consistent modeling by communication partners, and daily use.

How does Lingraphica compare to Tobii Dynavox and PRC-Saltillo?

These three companies dominate the dedicated SGD market in the United States. Here's an honest comparison based on publicly available information.

Lingraphica's real differentiator is the aphasia-specific clinical model. The vocabulary is built around acquired language loss rather than developmental language learning, and the company wraps the device in SLP telehealth support. If your family member had a stroke and has aphasia, Lingraphica is worth a serious look.

For a child with autism, apraxia, or another developmental communication difference, most SLPs with AAC specialization start the evaluation with Tobii Dynavox or PRC-Saltillo products. That's not a knock on Lingraphica. Those companies simply put more into pediatric vocabulary systems and child-appropriate access methods. See our guide on speech therapy for adults for more on adult AAC considerations, and childhood apraxia of speech for a closer look at pediatric AAC.

No brand wins for everyone. The best device is the one that fits the individual's motor, language, and cognitive profile after a real evaluation.

What do speech-language pathologists think about Lingraphica devices?

SLPs who specialize in aphasia generally see Lingraphica as a credible option for the right candidate. The company has been in the space long enough to earn clinical credibility, and Medicare accepts its devices, which means it meets federal DME supplier standards.

The common SLP concerns aren't about device quality. They're about fit. Lingraphica markets aggressively, and some clinicians have seen patients show up with a strong Lingraphica preference from advertising before an evaluation has even happened. That's the cart before the horse. A thorough AAC evaluation should drive device selection, not brand familiarity.

Some SLPs also note that Lingraphica's vocabulary system, strong as it is for aphasia, can feel less flexible than the Unity or LAMP Words for Life systems on PRC devices, or the Snap or TD Snap systems on Dynavox hardware. For users who need to grow their vocabulary fast, that can be a limit. Again: this is why the evaluation matters.

ASHA recommends that AAC evaluations be done by SLPs and that the evaluation include trialing multiple devices and systems before a recommendation. ^[3] Lingraphica's 30-day trial fits that approach. If your SLP hasn't suggested trialing other devices for comparison, it's fair to ask.

For families working through the speech therapy system for the first time, one principle holds up: good clinicians put the user's communication success ahead of brand loyalty. Ask your SLP directly: "What other devices are we comparing this to, and why is this one the right fit?"

How do you get started with Lingraphica if you think it might be right?

The fastest path: call Lingraphica at their main line (they publish it at lingraphica.com) and ask to speak with their funding and clinical team. They'll ask about diagnosis, insurance, and geography, then connect you with a Regional Sales Manager who can arrange the trial.

If you'd rather go through your own SLP first, that's entirely reasonable too. Give your SLP Lingraphica's provider resources page so they can review the clinical documentation requirements before starting the evaluation. Medicare's Letter of Medical Necessity for an SGD has specific required elements, and an SLP unfamiliar with the process can write a letter that gets denied.

A few practical things to have ready:

• Insurance cards (Medicare/Medicaid ID numbers, private plan info)
• Name and contact info for the prescribing physician
• Recent diagnostic records (stroke or brain injury documentation, prior SLP evaluations)
• A sense of the person's daily communication settings and which vocabulary matters most

For adults recovering from stroke or brain injury, the early intervention principle holds even in adult rehabilitation: starting AAC support sooner rather than waiting to see if natural speech recovers produces better long-term outcomes. That doesn't mean giving up on speech recovery. Many people use AAC and keep improving their natural speech at the same time. The two aren't in competition.

If you've recently had a stroke and are working through the communication rehabilitation system, know that you have real rights under Medicare and the Assistive Technology Act. An SGD is a medical necessity, not a luxury, when it's the right fit. ^[4][7]

Frequently asked questions

What conditions qualify someone for a Lingraphica AAC device?

Medicare and most insurers require documentation of a severe expressive communication disorder expected to be long-term, most commonly from stroke, traumatic brain injury, or progressive neurological disease like ALS. The person must have tried and found insufficient other communication methods, including unaided strategies. An SLP must document the medical necessity. Diagnosis alone doesn't guarantee coverage; functional communication limitations are what insurers evaluate.

Can children use Lingraphica devices?

Lingraphica's devices and vocabulary are designed mainly for adults with acquired aphasia. Children with autism, cerebral palsy, childhood apraxia of speech, or developmental language disorders are generally better served by devices from Tobii Dynavox or PRC-Saltillo, which have deeper pediatric vocabulary systems. If a child with aphasia from brain injury needs a device, Lingraphica could be evaluated, but an SLP should guide the choice after a full assessment.

How long does it take to get a Lingraphica device approved through insurance?

The process from initial evaluation to device delivery typically takes 4 to 12 weeks. The timeline depends on how quickly the SLP completes documentation, how responsive the insurer is to prior authorization requests, and whether an appeal is needed. Lingraphica's in-house funding team handles the insurance paperwork, which can speed things up compared to doing it yourself. Their 30-day free trial can happen while funding is pending.

Does using an AAC device stop someone from trying to speak?

No. Research consistently shows AAC does not suppress natural speech development or recovery. A systematic review in the American Journal of Speech-Language Pathology found AAC interventions had a predominantly positive effect on speech production. For aphasia recovery specifically, AAC and speech therapy work together; using a device for functional communication while continuing oral speech therapy is standard clinical practice.

What's the difference between TalkPath Therapy and the AllTalk device?

TalkPath Therapy is an app for practicing language and speech exercises, available on iOS and Android for a monthly subscription. The AllTalk is a dedicated hardware speech-generating device that Medicare can cover as Durable Medical Equipment when medically necessary. The app is for rehabilitation practice; the device is for real-time communication. They serve different purposes and can be used alongside each other.

Is Lingraphica covered by Medicaid?

Medicaid coverage for SGDs varies by state. All state Medicaid programs must address communication needs under federal law, but prior authorization requirements, approved vendors, and coverage limits differ widely. Lingraphica's funding team can check specific state Medicaid benefits. Some states require the device to be ordered through a Medicaid-approved DME supplier, which Lingraphica may or may not be depending on the state.

How does Lingraphica's free trial work?

Lingraphica offers a 30-day free home trial of the AllTalk device. A Regional Sales Manager coordinates the trial, typically after an initial call to assess fit. The trial device ships to the user's home. This period lets the user, their family, and their SLP see whether the device actually works in real daily settings before the funding process begins. There's no purchase obligation during the trial.

What languages does Lingraphica support?

Lingraphica's primary language support is English. Some features and vocabulary support Spanish, and additional language options may be available. If the user communicates mainly in a language other than English, ask Lingraphica directly about current language support before starting a trial, and discuss it with the evaluating SLP, since limited multilingual support can significantly affect how useful the device is.

Can someone with limited tech experience use a Lingraphica device?

Yes, this is one of Lingraphica's design priorities. The AllTalk interface uses large picture icons and a straightforward touch layout built for people with aphasia who may also have some cognitive or motor effects from stroke. Lingraphica provides setup support, and their SLP telehealth service can help with initial training. That said, all AAC devices require practice and partner training for best results.

What happens if my Lingraphica device breaks or needs repair?

Lingraphica provides a warranty on the AllTalk device; confirm the specific terms at purchase. Medicare-covered devices typically include a repair and replacement pathway through the DME supplier. If the device is within the warranty period, repairs are generally covered. Outside warranty, Medicare has provisions for repairs to covered DME. Contact Lingraphica's customer support directly for the current warranty terms and repair process.

Are there alternatives to Lingraphica for adults with aphasia?

Yes. Tobii Dynavox and PRC-Saltillo both make dedicated SGDs approved for Medicare coverage that adults with aphasia use. Some SLPs also work with lower-cost tablet-based AAC apps for less severe communication impairments, though those don't qualify for SGD Medicare coverage. The right alternative depends on the person's specific language and motor profile, which an AAC evaluation determines. Lingraphica's aphasia-specific focus is a genuine differentiator compared to broader-market competitors.

Does Lingraphica provide support to communication partners and family members?

Yes. Lingraphica's model includes family training as part of device setup, and TalkPath Live can connect family members and caregivers with SLPs for coaching on how to support AAC use. Communication partner training is essential; research consistently shows AAC outcomes are significantly better when the people around the device user know how to model its use and respond naturally.

Sources

1. ASHA, Augmentative and Alternative Communication overview: ASHA defines AAC as all ways of sharing ideas and feelings without talking, and classifies speech-generating devices as aided high-tech AAC.
2. ASHA, AAC Evidence Maps and Clinical Practice Guidelines: ASHA recommends AAC evaluations be conducted by SLPs with multiple device trials; evidence maps document AAC support for aphasia treatment.
3. CMS, Medicare Benefit Policy Manual, Durable Medical Equipment - Speech Generating Devices: Medicare Part B covers dedicated SGDs under HCPCS codes E2500-E2599 as DME when an SLP documents severe expressive communication disorder and medical necessity; Medicare pays 80% of allowed amount after Part B deductible.
4. Tobii Dynavox, Product Overview: Tobii Dynavox produces dedicated SGDs with strong eye gaze capabilities and broad pediatric and adult vocabulary systems, serving a wider population than Lingraphica's aphasia focus.
5. ASHA, AAC Funding and Coverage resources: Dedicated speech-generating devices typically retail in the range of $7,000 to $9,000 or more; most users obtain coverage through Medicare, Medicaid, or private insurance.
6. U.S. Department of Education, Individuals with Disabilities Education Act (IDEA) overview: IDEA requires school districts to provide assistive technology including AAC devices when an IEP team determines a child needs it for a free appropriate public education; all state Medicaid programs must address communication needs under federal law.
7. Millar, Light & Schlosser (2006), American Journal of Speech-Language Pathology, The impact of augmentative and alternative communication intervention on the speech production of individuals who use AAC: Systematic review found 'AAC interventions had a predominantly positive effect on the speech production of individuals who used AAC,' countering the myth that AAC suppresses natural speech.
8. Lingraphica-funded study, Aphasiology (2019), TalkPath Therapy efficacy: A 2019 Aphasiology study funded by Lingraphica found TalkPath Therapy users showed significant improvement on standardized aphasia measures compared to a waitlist control group.
9. Journal of Autism and Developmental Disorders (2021), systematic review on early AAC introduction in children with autism: A 2021 review found children who received AAC support earlier showed better communication outcomes, and there is no evidence that AAC hinders natural speech development.
10. Noridian Healthcare Solutions, Local Coverage Determination for Speech Generating Devices: The Medicare LCD for SGDs specifies coverage requires documentation of a severe expressive communication disorder expected to be long-term, with evidence that unaided communication and lower-tech options are insufficient.